Aethlon Medical (NASDAQ:AEMD) Share Price Crosses Above 200 Day Moving Average of $0.54

Shares of Aethlon Medical, Inc. (NASDAQ:AEMD) passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.54 and traded as high as $0.29. Aethlon Medical shares last traded at $0.26, with a volume of 31,598 shares trading hands.

Separately, ValuEngine lowered shares of Aethlon Medical from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st.

The business’s 50-day moving average price is $0.27 and its 200 day moving average price is $0.54. The company has a quick ratio of 1.47, a current ratio of 1.47 and a debt-to-equity ratio of 0.12. The company has a market capitalization of $5.10 million, a P/E ratio of -0.76 and a beta of 1.10.

Aethlon Medical (NASDAQ:AEMD) last released its quarterly earnings data on Wednesday, August 14th. The medical equipment provider reported ($0.11) EPS for the quarter, missing analysts’ consensus estimates of ($0.08) by ($0.03). The firm had revenue of $0.03 million for the quarter. Analysts anticipate that Aethlon Medical, Inc. will post -0.27 EPS for the current fiscal year.

An institutional investor recently bought a new position in Aethlon Medical stock. Cobblestone Capital Advisors LLC NY bought a new stake in Aethlon Medical, Inc. (NASDAQ:AEMD) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 76,323 shares of the medical equipment provider’s stock, valued at approximately $28,000. Cobblestone Capital Advisors LLC NY owned approximately 0.40% of Aethlon Medical at the end of the most recent reporting period. Institutional investors and hedge funds own 4.66% of the company’s stock.

Aethlon Medical Company Profile (NASDAQ:AEMD)

Aethlon Medical, Inc, a medical device company, focuses on creating devices that address unmet medical needs in health and biodefense worldwide. The company is developing Aethlon Hemopurifier, a clinical-stage therapeutic device that eliminates life-threatening viruses from the circulatory system of infected individuals.

Recommended Story: What economic reports are most valuable to investors?

Receive News & Ratings for Aethlon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical and related companies with's FREE daily email newsletter.